Wednesday 14 June 2017

Mechanical Mine Clearance System Market Growth, Trends, Key Players, Competitive Strategies and Forecasts 2017 - 2025 - Credence Research

​According to a new market research report published by Credence Research “Mechanical Mine Clearance System Market (Equipment Size – Light Machines (Upto 5 tons, Medium Machines (5 to 20 tons), Heavy Machines (More than 20 tons); Control Type – Manual Controlled, Remote Controlled) – Growth, Future Prospects, Competitive Analysis and Forecast, 2016 – 2024” the global mechanical mine clearance system market is estimated to expand with a CAGR of 2.7% from 2016 to 2024.
Market Insights
Mine clearance, also called as demining, is one of the most crucial operations of the five major mine actions. The process includes surveys, land mapping and minefield marking along with actual clearance of mines from the concerned land. Traditionally, the process is achieved through manual detection methods using metal detectors, well-trained dogs, prodder or an excavation kit. However, due to significant risk of casualties involved in manual detection, mechanical mine clearance systems have gained remarkable growth over the period of time.
Mechanical mine clearance systems are heavy vehicles designed to detonate the underlying mines with minimal damage to the equipment and operator. These are typically heavy machines having the most popular mass range starting from 5 tons to 15 tons (basic weight of the vehicle). Higher mass coupled with its structure, mechanical mine clearance form one of the safest methods for demining application. Due to substantial reliability and minimized casualty rate, the market growth is projected to remain robust during the forecast period. Nevertheless, high cost of the equipment and operation poses major challenge for the market growth.
On the basis of equipment size, the market is further segmented into three major segments viz. – lightweight (upto 5 tons), medium weight (5 tons to 20 tons) and heavy weight (more than 20 tons). Based on the mode of operation, the market is segment into remote controlled and manual controlled mine clearance system. As of 2015, the remotely controlled mine clearance system segment leads the overall market worldwide, in terms of revenue and volume.
Competitive Insights:
The overall mechanical mine clearance system market is quite fragmented in nature with large number of manufacturers worldwide. The concentration of these equipment vendors is centered majorly in Europe region. Apart from Europe, Asia Pacific possesses considerable number of market players. The most significant strategy adopted by the market players is providing machines capable of handling multiple tasks.
In addition, the market players are now more focused towards manufacturing remotely controlled equipment having higher operating range. This is followed so as to ensure optimum safety of the personnel operating in the mine field. Some of the major companies operating in the market include Aardvark Clear Mine Ltd., Armtrac Ltd., Digger DTR, Kawasaki Heavy Industries Ltd., Armtrac Ltd., Komatsu Ltd., Krohn, MineWolf Systems AG, Scanjack AB and Yamanashi Hitachi among others.
About Us:
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Who we are
Credence Research is a worldwide firm, containing more than 15 research consultants and almost 100 research and information professionals.
Our customers mirror our worldwide nature. Around 45% are in Europe, 30% in the Americas, 13% in Asia Pacific and 12% in the Middle East and Africa.
Our firm is intended to work as one. We are a solitary global research organization united by a solid arrangement of qualities, concentrated on customer effect.
What we do
We serve customers at each level of their organization, in whatever limit we can be most helpful, whether as a trusted counsel to top management or as a hands-on mentor for forefront representatives. For each engagement, we collect a group with the most suitable experience and ability.
No matter the challenge, we concentrate on delivering functional and persevering results, and preparing our customers to develop and lead. We join forces with customers to place suggestions into practice. Our research specialist work straightforwardly with customers over long stretches to create workforce aptitudes, drive operational change, and apply new working strategies.
Contact:
Name: Chris Smith
Designation: Global Sales Manager
Ph: 1-800-361-8290
Posted by at No comments:

Managed Equipment Services Market Growth, Trends, Key Players, Competitive Strategies and Forecasts 2017 - 2025 - Credence Research

​In a new market research report published by Credence Research “Managed Equipment Services Market (Engagement Model – End-to-end MES and On-demand MES) – Growth, Future Prospects and Competitive Analysis, 2016 – 2024”, the global managed equipment services market is estimated to expand with a CAGR of 13.3% from 2016 to 2024.
Market Insights
Managed equipment service (MES) is the bundling of various aspects related medical equipment such as procurement, management, maintenance, upgrades, repairs and replacement, among others under a single multi-year contract.
Deployment of the MES business model has enabled hospitals to procure and make use of the latest and most advanced medical equipment available in the market.
In addition, the hospitals are able to ensure optimum repairing and maintenance services as a part of the signed contract. Thereby, hospitals can worry less regarding the capital investments towards medical equipment and focus more towards better care delivery and higher patient satisfaction. As a result, MES has offered a viable solution to numerous healthcare providers across the world to ensure operational and financial efficiency with reduced risks pertaining to medical equipment and hospital budgets.
Over the period of time, MES has witnessed significant adoption (majorly in the U.S. and Western Europe) due to poor capital expenditure planning, insufficient service management and need for maintaining upgraded equipment in organizations. With the rising overall healthcare IT spending, the demand for MES is estimated to rise significantly during the forecast period.
Competitive Insights:
The managed equipment services market is highly competitive in nature with significant consolidation. The market players include medical equipment manufacturers as well as third-party companies providing solely managed equipment service. The most prominent companies operating in the market include Siemens Healthcare GmbH (Siemens Healthineers), GE Healthcare and Koninklijke Philips NV. These companies have emphasis on development of medical devices and services according to the continuously changing government regulation subject to healthcare industry. The companies also focus on expanding their reach into emerging markets of Asia Pacific, Middle East, Africa and Latin America.
Key Trends:
  • Focus on providing flexible solutions
  • Long term service agreements with healthcare organizations
  • Development of advanced medical equipment with higher accuracy and compliance with regulations
About Us:
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Who we are
Credence Research is a worldwide firm, containing more than 15 research consultants and almost 100 research and information professionals.
Our customers mirror our worldwide nature. Around 45% are in Europe, 30% in the Americas, 13% in Asia Pacific and 12% in the Middle East and Africa.
Our firm is intended to work as one. We are a solitary global research organization united by a solid arrangement of qualities, concentrated on customer effect.
What we do
We serve customers at each level of their organization, in whatever limit we can be most helpful, whether as a trusted counsel to top management or as a hands-on mentor for forefront representatives. For each engagement, we collect a group with the most suitable experience and ability.
No matter the challenge, we concentrate on delivering functional and persevering results, and preparing our customers to develop and lead. We join forces with customers to place suggestions into practice. Our research specialist work straightforwardly with customers over long stretches to create workforce aptitudes, drive operational change, and apply new working strategies.
Contact:
Name: Chris Smith
Designation: Global Sales Manager
Ph: 1-800-361-8290
Posted by at No comments:
Labels: ,

Asthma Therapeutics Market Analysis, opportunities Trends And Industry Strategies 2017 - 2025 - Credence Research

​The latest market report published by Credence Research, Inc. “Global Asthma Therapeutics Market– Growth, Future Prospects and Competitive Analysis, 2016 – 2024” the global asthma therapeutics market was valued at US$ 19.35Bn in terms of value in 2015, and is expected to reach US$ 23.4Bn by 2024, expanding at a CAGR of 2.1% from 2016 to 2024.
Market Insights
Asthma is a chronic respiratory disease that affects the airways of the lung. There is no cure for asthma but it can be controlled by using different asthma symptoms controlling medications. Factors such as rise in asthma prevalence, increased environmental pollution, promising late-stage pipeline molecules and expected use of personalized medicine would further influence the market growth during forecast period. The global asthma therapeutics market is segmented on the basis of drug class, product type, route of administration and various geographic region.
Browse the full report Global Asthma Therapeutic Market- Growth, Future Prospects and Competitive Analysis, 2016 – 2024 at http://www.credenceresearch.com/report/global-asthma-therapeutics-market
There are mainly three types of drugs classes are used to treat asthma, it includes bronchodilators, anti-inflammatories and combination therapy. Currently once daily dose of combination drug consisting of beta agonist and inhaled corticosteroids trend is observed in the market and it is anticipated to grow moderately during forecast period. Currently, only one biologic Xolair is approved in market, but due to more efficacy with less side effects biologics market will preferred choice to treat asthma in future. Global asthma therapeutics market is segmented by product type such as dry powder inhalers, metered dose inhalers (MDIs), mist inhaler and nebulizers. Currently MDIs are dominating the market as they deliver consistent dose of medication directly to the lungs, however in recent years consumption pattern is shifting towards use of dry powder inhalers as they deliver more accurate dose with ease of use.
On the basis of route of administration, asthma therapeutics market is segmented as oral, inhalational and parenteral medication. In base year 2015, inhalation drug is major revenue contributing segment, factors such as rapid onset of action, less systemic toxicity and higher concentration availability at the site action are driving the market growth of inhalation asthma medication. Advair, Spiriva and Symbicort are the major contributors in inhaled asthma drug market. However patent expiry of some blockbusters drugs such as Symbicort and Flovent leads to reduce the overall revenue in global inhalation drug market. Currently North America is major revenue generating segment in global asthma therapeutics and it will show significant growth during forecast period 2016-2024. Increase in prevalence, rising population, high cost of medication, increasing demand of asthma medication, promising pipeline molecule would further drive the market growth in North America.
Market Competition Assessment:
The asthma therapeutics market is observed as the most competitive and comprises of large number of players. However, currently market is dominated by few players such as Abbott Laboratories, AstraZeneca, Becton, Dickinson and Company, Boehringer Ingelheim GmbH, Chiesi Farmaceutici, F. Hoffmann-La Roche, GlaxoSmithKline Plc., Merck& Co., Inc., Pfizer, Philips Healthcare, Sanofi-Aventis SA, Sunovion Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd. and others.
Key Market Movements:
Increase in prevalence, rising environmental pollution, promising late stage pipeline molecules, introduction of new technologies and expected use of personalized medicine would drive the market growth during forecast period.
Funding by the government agencies and private organizations, increasing healthcare awareness and economic development in some countries are key market growth drivers for the asthma therapeutics market.
Factors such as patent expiry of blockbuster drugs and under diagnoses of disease negatively impacting the market growth of asthma therapeutics market.
About Us:
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Who we are
Credence Research is a worldwide firm, containing more than 15 research consultants and almost 100 research and information professionals.
Our customers mirror our worldwide nature. Around 45% are in Europe, 30% in the Americas, 13% in Asia Pacific and 12% in the Middle East and Africa.
Our firm is intended to work as one. We are a solitary global research organization united by a solid arrangement of qualities, concentrated on customer effect.
What we do
We serve customers at each level of their organization, in whatever limit we can be most helpful, whether as a trusted counsel to top management or as a hands-on mentor for forefront representatives. For each engagement, we collect a group with the most suitable experience and ability.
No matter the challenge, we concentrate on delivering functional and persevering results, and preparing our customers to develop and lead. We join forces with customers to place suggestions into practice. Our research specialist work straightforwardly with customers over long stretches to create workforce aptitudes, drive operational change, and apply new working strategies.
Contact:
Name: Chris Smith
Designation: Global Sales Manager
Ph: 1-800-361-8290
Posted by at No comments:
Labels: ,

Friction Stir Welding Market Forecast And opportunities Trends, Size, Drivers 2017 - 2025 - Credence Research

​According to a new market report published by Credence Research, Inc., “Global Friction Stir Welding Market(By Equipment Type (Fixed Friction Stir Welding, Adjustable Friction Stir Welding, and Self-reacting Friction Stir Welding), By End-use Application (Shipbuilding and Offshore, Automotive, Aerospace, Fabrication, and Others)) – Growth, Share, Opportunities, Competitive Analysis, and Forecast 2016 – 2024” the global friction stir welding market is expected to reach US$ 887.8 Mn, expanding at a compound annual growth rate of 7.1% during the forecast period 2016 – 2024.
Product Insights
Friction stir welding (FSW) is a solid-state joining process that uses a non-consumable tool to join two facing work pieces without melting the work piece material. Invented in 1991, the friction stir welding (FSW) process was developed at, and is patented by, The Welding Institute (TWI) in Cambridge, United Kingdom. The development of this process was a significant change from the conventional rotary motion and linear reciprocating friction welding processes. It provided a great deal of flexibility within the friction welding process group. The process advantages result from the fact that the FSW process takes place in the solid phase below the melting point of the materials to be joined. Additional benefits include its ability to join materials that are difficult to fusion weld.
Competitive Insights:
Some of the leading, promising, and emerging players identified in the global friction stir welding market include Beijing FSW Technology Co, Ltd., Hitachi High-Technologies Corporation, The ESAB Group, Inc., Manufacturing Technology Inc., KUKA Systems GmbH, MegaStir, Gatwick Technologies, ETA Technology Pvt. Ltd., Grenzebach Maschinenbau GmbH, EWI, FOOKE GmbH, General Tool Company, PaR Systems, RV Machine Tools, and SAPA Group among others.
The global friction stir welding market is highly competitive and it is requisite for manufacturers to understand requirements of each end-use vertical and develop solution accordingly. In order to understand distinct requirements regarding process monitoring and control, friction stir welding equipment manufacturers are required to develop cordial relationship with customers.
In addition, the manufacturers also need to work with industry groups that are involved in the development of standards and regulations. Conducting promotional campaign and participating in industrial exhibitions is crucial to manufacturer’s sustainability as it creates awareness regarding product benefits. Focus on product enhancement through technology development remains the cut-throat strategy for manufacturers in the global friction stir welding market.
Segmentation Analysis:
The global friction stir welding market was led by the Asia Pacific region, accounting for over 42% of the global market revenue. The region is home to huge manufacturing industry. Positive outlook of the manufacturing industry, especially in China and India is expected to have positive impact on the overall market demand in the region.
In terms of equipment type, fixed friction stir welders dominated the overall demand, while adjustable friction stir welder are presumed to witness maximum adoption on account of their ability to weld materials of varied thickness with accuracy and less manual work.
About Us:
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Who we are
Credence Research is a worldwide firm, containing more than 15 research consultants and almost 100 research and information professionals.
Our customers mirror our worldwide nature. Around 45% are in Europe, 30% in the Americas, 13% in Asia Pacific and 12% in the Middle East and Africa.
Our firm is intended to work as one. We are a solitary global research organization united by a solid arrangement of qualities, concentrated on customer effect.
What we do
We serve customers at each level of their organization, in whatever limit we can be most helpful, whether as a trusted counsel to top management or as a hands-on mentor for forefront representatives. For each engagement, we collect a group with the most suitable experience and ability.
No matter the challenge, we concentrate on delivering functional and persevering results, and preparing our customers to develop and lead. We join forces with customers to place suggestions into practice. Our research specialist work straightforwardly with customers over long stretches to create workforce aptitudes, drive operational change, and apply new working strategies.
Contact:
Name: Chris Smith
Designation: Global Sales Manager
Ph: 1-800-361-8290
Posted by at No comments:
Labels: ,

Antibody Drug Conjugate Market Share, Trends, Global Price, Company Profiles, Demand, Insights 2017 - 2025 - Credence Research

​According to the latest report published by Credence Research, Inc. “Antibody Drug Conjugate Market– (Drug Type – Adcetris and Kadcyla): Market Growth, Future Prospects and Competitive Analysis, 2016-2023,” the market was valued at USD 1.3 Bn in 2015, and is expected to reach USD 29.3 Bn by 2022, expanding at a CAGR of 41.7% from 2016 to 2024.
Market Insights
Antibody Drug Conjugates are monoclonal antibodies that are attached to biologically active drugs such as chemotherapeutic drugs, radioactive isotopes, cytokines or cytotoxins via chemical linkers with liable bonds. They combine the unique targeting property of monoclonal antibodies with the cancer cell killing ability of cytotoxic drugs. These allow discrimination between healthy and diseased tissues. Currently marketed drugs suffers from various stipulations like low potency, lack of specificity and adverse effects.
Browse the full report Antibody Drug Conjugate Market: Market Growth, Future Prospects and Competitive Analysis, 2016-2024 at http://www.credenceresearch.com/report/antibody-drug-conjugate-market
This has forced the pharmaceutical and research companies to develop therapeutics that can overcome these barriers. Commercializing antibody drug conjugates have overcome these scenarios and improve the medical conditions. The currently marketed antibody drug conjugate drugs are Adcetris (Seattle Genetics) and Kadcyla (Genentech/Roche) followed by several Antibody Drug Conjugates (ADCs) in pipeline showcase the potential for innovations in this market.
In base year 2015, North America accounted for the largest market in the antibody drug conjugate market due to the presence of major pharmaceutical companies working on the development of antibody drug conjugate drugs. Moreover, one of the prime reason of North America’s dominance in the antibody drug conjugates market is the fast-track approval and commercialization of ADCs in the region as compared to other geographical regions. Europe held the second largest market for antibody drug conjugates market. Kadcyla, one of the two drugs that are marketed currently is manufactured by the Europe based pharmaceutical giant, Roche. Additionally, Europe was the second region after where the commercialization of the ADCs were approved on a fast-track basis. Asia pacific is anticipated to be the fastest growing segment in the antibody drug conjugate market due to the approval of ADCs in Japan, China.
Market Competition Assessment:
The antibody drug conjugate market currently possesses only two companies having their drugs marketed. However, many companies have their molecules in the clinical development stage which hit market during the forecast period. The companies include Immunomedics, Spirogen, Pfizer, Roche/Genentech, Oxford BioTherapeutics, and Others.
Key Market Movements:
The Antibody Drug Conjugate market is still in infancy stage with only Adcetris and Kadcyla are the only two marketed drugs. However, there are several ADCs under development, with most of them being developed for oncological indication.
Drug developers and venture capital firms are investing huge amount of money in biologics and it remains to be seen what proportion of this will be directed towards ADCs.
About Us:
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Who we are
Credence Research is a worldwide firm, containing more than 15 research consultants and almost 100 research and information professionals.
Our customers mirror our worldwide nature. Around 45% are in Europe, 30% in the Americas, 13% in Asia Pacific and 12% in the Middle East and Africa.
Our firm is intended to work as one. We are a solitary global research organization united by a solid arrangement of qualities, concentrated on customer effect.
What we do
We serve customers at each level of their organization, in whatever limit we can be most helpful, whether as a trusted counsel to top management or as a hands-on mentor for forefront representatives. For each engagement, we collect a group with the most suitable experience and ability.
No matter the challenge, we concentrate on delivering functional and persevering results, and preparing our customers to develop and lead. We join forces with customers to place suggestions into practice. Our research specialist work straightforwardly with customers over long stretches to create workforce aptitudes, drive operational change, and apply new working strategies.
Contact:
Name: Chris Smith
Designation: Global Sales Manager
Ph: 1-800-361-8290
Posted by at No comments:
Labels: ,
Subscribe to: Posts (Atom)